Rachel E. Simmonds

5.2k total citations
43 papers, 1.8k citations indexed

About

Rachel E. Simmonds is a scholar working on Epidemiology, Hematology and Immunology. According to data from OpenAlex, Rachel E. Simmonds has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Hematology and 11 papers in Immunology. Recurrent topics in Rachel E. Simmonds's work include Mycobacterium research and diagnosis (17 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Infectious Diseases and Mycology (7 papers). Rachel E. Simmonds is often cited by papers focused on Mycobacterium research and diagnosis (17 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Infectious Diseases and Mycology (7 papers). Rachel E. Simmonds collaborates with scholars based in United Kingdom, United States and France. Rachel E. Simmonds's co-authors include Brian M. J. Foxwell, David A. Lane, Michael J. McKenna, Stephen High, Belinda S. Hall, Joy Ogbechi, Richard Odame Phillips, Anne E. Willis, Suely M. Rezende and Kirsti Hill and has published in prestigious journals such as Blood, Annals of Internal Medicine and Molecular Cell.

In The Last Decade

Rachel E. Simmonds

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel E. Simmonds United Kingdom 24 633 489 415 393 212 43 1.8k
T M McIntyre United States 11 668 1.1× 267 0.5× 567 1.4× 999 2.5× 99 0.5× 11 2.5k
Marguerite S. Buzza United States 19 258 0.4× 210 0.4× 659 1.6× 475 1.2× 83 0.4× 29 1.7k
Lea M. Beaulieu United States 19 743 1.2× 162 0.3× 586 1.4× 478 1.2× 146 0.7× 23 1.8k
Robert Liwski Canada 26 293 0.5× 137 0.3× 562 1.4× 669 1.7× 72 0.3× 89 1.9k
P. K. Das Netherlands 16 99 0.2× 472 1.0× 335 0.8× 1.0k 2.6× 34 0.2× 26 2.4k
Ina Fabian Israel 29 366 0.6× 190 0.4× 683 1.6× 557 1.4× 123 0.6× 91 2.0k
Sachiko Kanaji United States 20 443 0.7× 97 0.2× 341 0.8× 335 0.9× 80 0.4× 42 1.3k
Fadila Guessous United States 22 153 0.2× 149 0.3× 1.5k 3.6× 247 0.6× 221 1.0× 61 2.6k
Fumihiko Takatsuki Japan 16 373 0.6× 86 0.2× 287 0.7× 496 1.3× 127 0.6× 24 1.5k
Narcis I. Popescu United States 15 239 0.4× 253 0.5× 554 1.3× 600 1.5× 71 0.3× 27 1.3k

Countries citing papers authored by Rachel E. Simmonds

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Simmonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Simmonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Simmonds more than expected).

Fields of papers citing papers by Rachel E. Simmonds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Simmonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Simmonds. The network helps show where Rachel E. Simmonds may publish in the future.

Co-authorship network of co-authors of Rachel E. Simmonds

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Simmonds. A scholar is included among the top collaborators of Rachel E. Simmonds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Simmonds. Rachel E. Simmonds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ogden, Jane, et al.. (2024). Multisensory medical illustrations of Buruli ulcer for improved disease detection, help seeking behaviour and adherence to treatment. Journal of Visual Communication in Medicine. 47(1). 8–20.
7.
O’Keefe, Sarah, Pratiti Bhadra, Guanghui Zong, et al.. (2022). Synthesis, Biological Evaluation and Docking Studies of Ring-Opened Analogues of Ipomoeassin F. Molecules. 27(14). 4419–4419. 1 indexed citations
8.
Hsieh, Louise Tzung-Harn, Scott J Dos Santos, Belinda S. Hall, et al.. (2022). Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions. PLoS Pathogens. 18(1). e1010280–e1010280. 6 indexed citations
9.
Hall, Belinda S., Scott J Dos Santos, Louise Tzung-Harn Hsieh, et al.. (2021). Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity. Autophagy. 18(4). 841–859. 12 indexed citations
10.
Hall, Belinda S., A. Zaki, Peter Mayerhofer, et al.. (2020). Structure of the Inhibited State of the Sec Translocon. Molecular Cell. 79(3). 406–415.e7. 40 indexed citations
11.
Yotsu, Rie, Koichi Suzuki, Rachel E. Simmonds, et al.. (2018). Buruli Ulcer: a Review of the Current Knowledge. Current Tropical Medicine Reports. 5(4). 247–256. 65 indexed citations
12.
Hall, Belinda S., Kirsti Hill, Michael J. McKenna, et al.. (2014). The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER. PLoS Pathogens. 10(4). e1004061–e1004061. 117 indexed citations
13.
Brenner, Catherine, Rachel E. Simmonds, Simon Wood, et al.. (2012). TLR Signalling and Adapter Utilization in Primary Human In vitro Differentiated Adipocytes. Scandinavian Journal of Immunology. 76(4). 359–370. 18 indexed citations
14.
Simmonds, Rachel E., Ferdinand Lali, Tim Smallie, Pamela L. C. Small, & Brian M. J. Foxwell. (2009). Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism. The Journal of Immunology. 182(4). 2194–2202. 70 indexed citations
15.
Sacre, Sandra, Bernard Gregory, Rachel E. Simmonds, et al.. (2008). Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures. The Journal of Immunology. 181(11). 8002–8009. 79 indexed citations
16.
Simmonds, Rachel E. & Brian M. J. Foxwell. (2008). Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation. Lara D. Veeken. 47(5). 584–590. 296 indexed citations
17.
Biguzzi, Eugenia, Cristina Razzari, David A. Lane, et al.. (2005). Molecular diversity and thrombotic risk in protein S deficiency: The PROSIT study. Human Mutation. 25(3). 259–269. 36 indexed citations
18.
White, Stephen J., Rachel E. Simmonds, David A. Lane, & Andrew H. Baker. (2005). Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning. Peptides. 26(7). 1264–1269. 5 indexed citations
19.
Simmonds, Rachel E., et al.. (2003). Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex. Blood. 103(4). 1192–1201. 155 indexed citations
20.
Simmonds, Rachel E., H. Ireland, G Kunz, et al.. (1996). Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Blood Coagulation & Fibrinolysis. 7(3). 373–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026